# Protective Effects of Myrtus communis Essential Oil Against Bisphenol A‐Induced Metabolic Dysfunction‐Associated Fatty Liver Disease in Wistar Rats

**Authors:** Mhimdi Mariem, Selmi Slimen, Amira Zammali, Manel Hraoui, Soumaya Wahabi, Dallacqua Stefano, Sebai Hichem

PMC · DOI: 10.1002/fsn3.71520 · Food Science & Nutrition · 2026-02-08

## TL;DR

This study shows that Myrtus communis essential oil can protect against liver damage caused by BPA in rats, similar to vitamin E.

## Contribution

The study demonstrates the protective potential of Myrtus communis essential oil against BPA-induced MASLD in a rat model.

## Key findings

- BPA exposure increased liver enzymes, lipid levels, and oxidative stress in rats.
- EOMC reduced triglycerides and oxidative stress markers in a dose-dependent manner.
- Liver histology showed EOMC significantly attenuated BPA-induced steatosis.

## Abstract

Endocrine disruptors such as bisphenol A (BPA) are increasingly associated with metabolic disorders, including metabolic dysfunction‐associated fatty liver disease (MASLD). This preclinical study investigates the effect of BPA on liver function and lipid metabolism in Wistar rats and evaluated the protective potential of 
Myrtus communis
 essential oil (EOMC) and vitamin E (Vit E). MASLD was induced in Wistar rats by oral administration of BPA (100 mg/kg/day) for 30 days. Rats were co‐treated with EOMC at doses of 50,100, or 200 mg/kg body weight, or Vit E at 100 mg/kg. Liver and kidney function markers, lipid profiles, oxidative stress parameters, and organ histology were assessed. BPA exposure significantly increased plasma liver enzymes (AST: 195,76 ± 4,47 U/L, ALT: 91,05 ± 0,58 U/L) and lipid levels (triglycerides: 1,30 ± 0,13 g/L) compared to controls, and elevated oxidative stress markers, including malondialdehyde (MDA). Co‐treatment with EOMC improved these parameters in a dose‐dependent manner. At 200 mg/kg, EOMC reduced plasma triglycerides 0,62 ± 0,09 g/L, corresponding to an approximate 52% decrease compared to the BPA‐only group, along with an approximately 84% reduction in hepatic MDA levels. Liver histology confirmed marked attenuation of steatosis and hepatocellular damage. Vitamin E showed similar protective effects, though slightly less pronounced. Both EOMC and Vit E demonstrated potential in mitigating against BPA‐induced MASLD. These findings indicate that EOMC may have a protective effect against fatty liver changes in this experimental model, but further studies are needed to confirm its relevance in humans.

Exposure to bisphenol A (BPA) induced hepatic steatosis associated with metabolic dysfunction (MASLD) in Wistar rats, characterized by dyslipidemia, oxidative stress, and hepatic steatosis. Co‐treatment with essential oil of 
myrtus communis
 (EOMC) improved markers of liver function, lipid profile, and antioxidant status, with histological improvement.

## Linked entities

- **Chemicals:** bisphenol A (PubChem CID 6623), vitamin E (PubChem CID 14985), malondialdehyde (PubChem CID 10964)
- **Diseases:** MASLD (MONDO:0013209)

## Full-text entities

- **Diseases:** hepatocellular damage (MESH:D056486), metabolic disorders (MESH:D008659), MASLD (MESH:D005234)
- **Chemicals:** lipid (MESH:D008055), BPA (MESH:C006780), EOMC (-), Vit E (MESH:D014810), MDA (MESH:D008315), triglycerides (MESH:D014280)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883692/full.md

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12883692/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883692/full.md

---
Source: https://tomesphere.com/paper/PMC12883692